通过GAN增强的深度学习来改善阿尔茨海默病的分类和纵向大脑变化分析
Purushottam Pandey1, Surbhi Bhatia Khan2,3,4, Jyoti Pruthi1
1Manav Rachna University (MRU), Faridabad, Haryana, India.
Frontiers in medicine
|July 2, 2025
概括
这项研究引入了一种先进的AI模型,使用深度学习来准确检测阿尔茨海默病 (AD) 和预测其进展. 人工智能实现了高精度,有助于更快的诊断和个性化的AD治疗计划.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 医学成像分析 医学成像分析
背景情况:
- 传统的阿尔茨海默病 (AD) 诊断是耗时且容易出现错误的.
- 现有的方法与大型数据集扎,导致分类速度较慢,可能不准确.
- 人工智能,机器学习 (ML) 和深度学习 (DL) 的进展为改善AD检测提供了潜在的解决方案.
研究的目的:
- 提高阿尔茨海默病 (AD) 检测和分类的准确性和效率.
- 开发一种能够预测AD进展的AI模型.
- 将深度学习与大脑模拟集成在一起,以更深入地了解AD机制.
主要方法:
- 利用深度学习架构,包括具有新层 (PDPO,DCK) 的ResNet101用于从ADNI和OASIS数据集中提取特征.
- 使用长期短期记忆 (LSTM) 网络将个人分为认知正常 (CN),轻度认知障碍 (MCI) 和AD类别.
- 综合生成对抗网络 (GANs) 来确定AD的进展 (渐进性与非渐进性).
- 集成的大脑模拟模型用于可视化和预测AD演变.
主要成果:
- 实现了高准确率:在ADNI数据集上为0.9931,在OASIS数据集上为0.9985.
- GAN模型成功地确定了AD的渐进性质.
- 综合方法为个性化治疗提供了对AD的细微了解.
结论:
- 拟议的AI框架显著提高了AD诊断的准确性和效率.
- 这种方法通过预测疾病进展,促进了个性化治疗策略.
- 人工智能和大脑模拟的整合为AD的神经机制提供了宝贵的见解.
关键词:
阿迪尼阿迪尼是什么意思阿尔茨海默氏症的疾病是阿尔茨海默氏症.在OASIS数据库中,OASIS的数据集是:在ResNet101中使用ResNet101.生成性的对抗性网络.长期的短期记忆 长期的短期记忆更多相关视频
相关概念视频
Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265


